Holland Capital has sold Quantib to RadNet

Quantib B.V., a portfolio company of Holland Capital, has been sold to RadNet, Inc.

Founded in 2012 and headquartered in the Netherlands, Quantib is a leading radiology artificial intelligence and machine learning company focusing on clinical solutions for prostate cancer and neurodegeneration.

RadNet is a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers in the USA.

Holland Capital is one of the first independent private equity firms in the Netherlands. Since 1981, they have been successfully and responsibly investing in promising small and medium-sized Dutch businesses with growth ambitions. With a clear investment strategy, they anticipate long-term trends in attractive growth markets, focusing on the healthcare and technology sectors. Their experienced and dedicated investment team knows what entrepreneurship is.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Quantib B.V.